Seguir
Jordan Elm
Jordan Elm
Professor of Biostatistics, Medical University of South Carolina
Email confirmado em musc.edu
Título
Citado por
Citado por
Ano
Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA
SC Johnston, JD Easton, M Farrant, W Barsan, RA Conwit, JJ Elm, ...
New England Journal of Medicine 379 (3), 215-225, 2018
10402018
Evolution of the modified Rankin scale and its use in future stroke trials
JP Broderick, O Adeoye, J Elm
Stroke 48 (7), 2007-2012, 2017
6712017
Randomized trial of three anticonvulsant medications for status epilepticus
J Kapur, J Elm, JM Chamberlain, W Barsan, J Cloyd, D Lowenstein, ...
New England Journal of Medicine 381 (22), 2103-2113, 2019
4662019
The impact of depressive symptoms in early Parkinson disease
B Ravina, R Camicioli, PG Como, L Marsh, J Jankovic, D Weintraub, ...
Neurology 69 (4), 342-347, 2007
4012007
Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA
SC Johnston, JD Easton, M Farrant, W Barsan, RA Conwit, JJ Elm, ...
N Engl J Med 379 (3), 215-225, 2018
2502018
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial
KN Sheth, JJ Elm, BJ Molyneaux, H Hinson, LA Beslow, GK Sze, ...
The Lancet Neurology 15 (11), 1160-1169, 2016
2202016
Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling …
Y Pan, JJ Elm, H Li, JD Easton, Y Wang, M Farrant, X Meng, AS Kim, ...
JAMA neurology 76 (12), 1466-1473, 2019
1952019
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
JM Chamberlain, J Kapur, S Shinnar, J Elm, M Holsti, L Babcock, ...
The Lancet 395 (10231), 1217-1224, 2020
1852020
Transcranial direct current stimulation vs sham stimulation to treat aphasia after stroke: a randomized clinical trial
J Fridriksson, C Rorden, J Elm, S Sen, MS George, L Bonilha
JAMA neurology 75 (12), 1470-1476, 2018
1842018
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial
K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ...
Jama 313 (6), 584-593, 2015
1732015
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design
SC Johnston, JD Easton, M Farrant, W Barsan, H Battenhouse, R Conwit, ...
International Journal of Stroke 8 (6), 479-483, 2013
1682013
Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin scale
N Chaisinanunkul, O Adeoye, RJ Lewis, JC Grotta, J Broderick, TG Jovin, ...
Stroke 46 (8), 2238-2243, 2015
1662015
Oral anticoagulation and functional outcome after intracerebral hemorrhage
A Biffi, JB Kuramatsu, A Leasure, H Kamel, C Kourkoulis, K Schwab, ...
Annals of neurology 82 (5), 755-765, 2017
1492017
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
L Neurol
Lancet Neurol 14 (8), 795-803, 2015
1302015
The established status epilepticus trial 2013
T Bleck, H Cock, J Chamberlain, J Cloyd, J Connor, J Elm, N Fountain, ...
Epilepsia 54, 89-92, 2013
1282013
Fall frequency and risk assessment in early Parkinson's disease
TS Voss, JJ Elm, CL Wielinski, MJ Aminoff, D Bandyopadhyay, KL Chou, ...
Parkinsonism & related disorders 18 (7), 837-841, 2012
1122012
Pilot study of intravenous glyburide in patients with a large ischemic stroke
KN Sheth, WT Kimberly, JJ Elm, TA Kent, P Mandava, AJ Yoo, G Thomalla, ...
Stroke 45 (1), 281-283, 2014
922014
Glyburide is associated with attenuated vasogenic edema in stroke patients
WT Kimberly, TWK Battey, L Pham, O Wu, AJ Yoo, KL Furie, AB Singhal, ...
Neurocritical care 20, 193-201, 2014
892014
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
JT Connor, JJ Elm, KR Broglio, Esett and Adapt-It Investigators
Journal of clinical epidemiology 66 (8), S130-S137, 2013
882013
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs
BC Tilley, YY Palesch, K Kieburtz, B Ravina, P Huang, JJ Elm, K Shannon, ...
Neurology 66 (5), 628-633, 2006
872006
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20